the patients displayed a range of periodontal disease from gingivitis to complete edentia , but periodontal disease status did not appear to influence the salivary behavior of hmba , which mirrored that of the drug in plasma , with concentrations of hmba increasing in both fluids during the first 12-16 h of infusion .
C0017574
gingivitis
C0017563
periodontal disease